[1]
A. Forštnarič, A. Stajan, and N. Piko, “Balancing the Benefits and Risks of SGLT2 Inhibitors: Koristi in pasti zdravljenja s SGLT-2 zaviralci”, AMB, vol. 19, no. 1, pp. 10–17, Jun. 2026, doi: 10.18690/actabiomed.300.